Otsuka Pharmaceutical's Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge

Otsuka Pharmaceutical Co., Ltd. announces that its U.K. subsidiary Astex Pharmaceuticals has entered into a newly-formed consortium that will be hosted at the University of Cambridge.

PRESS RELEASE

Otsuka Pharmaceutical Co., Ltd. announces that its U.K. subsidiary Astex Pharmaceuticals has entered into a newly-formed consortium that will be hosted at the University of Cambridge.

(For detailed information please refer to the July 28 press release by the University of Cambridge:http://www.cam.ac.uk/research/news)

The consortium brings together the University of Cambridge, two other Cambridge- area academic institutes and three U.K.-based pharmaceutical companies to collectively develop precision medicines for some of the most globally devastating diseases. The consortium is pooling the specialized knowledge of academic institutions with the drug development capabilities of the pharmaceutical industry with the goal of delivering better drugs to patients.